Announcements
- EQUASENS : Résultats Annuels 2023
- Equasens: 2023 Annual Results
- EQUASENS : BILAN SEMESTRIEL S2-2023 DU CONTRAT DE LIQUIDITE
- Equasens: 2023 revenue: €219.7m, +2.6%
- EQUASENS : Chiffre d’affaires 2023 : +2,6 % à 219,7 M€
- EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE
- Equasens: Acquisition of a majority stake in DIGIPHARMACIE
- EQUASENS : Evolution du Comité de Direction du Groupe Equasens
- Equasens: Changes in the Equasens Group Executive Committee
- EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 15.17m |
Free float | 5.06m |
P/E (TTM) | 18.15 |
Market cap | 880.10m EUR |
EPS (TTM) | 3.20 EUR |
Data delayed at least 15 minutes, as of Dec 30 1899.
More ▼